MAPK3 and breast carcinoma: To shed light on possible sources of perturbation in the MAPK signaling activity in breast tumors, the protein phosphor-isoform profiles of MEK1, MEK2, and ERK1/2 were measured in MDA-MB-231 breast cancer cell lines treated with small-molecule kinase inhibitors.